$ADXN - Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration.
Therapeutics Company Eligible For Up to $330 Million on Successful Achievement of Prespecified Regulatory
Therapeutics Company Eligible For Up to $330…
Therapeutics Company Eligible For Up to $330 Million on Successful Achievement of Prespecified Regulatory
$ADXN - Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration.